Ophthalmology software ILLUME

screeningAI-assistedeye

Efficient screening for diabetic retinopathy enables early intervention AI automatically detects early signs of disease and classifies the results according to severity The unique confocal technology of the iCare DRSplus fundus imaging system enables screening of all patients, also those with ocular media opacities Swift, intuitive, and fully automated operations, and images successful on the first take Screening for other eye pathologies in the future Fast and effortless screening for diabetic patients in all care settings using artificial intelligence iCare ILLUME is a unique combination of specialized screening software with AI and TrueColor Confocal fundus imaging. Key advantages include a fully automated workflow, high-quality detailed images without dilation, and the future option to share referrals also outside of the source organization. Reliable and efficient review of the images by AI saves valuable time, enables early intervention and helps to increase the regional screening coverage. For the first time, screening is possible for all patients, including those with ocular media opacities such as cataract and vitreous cloudiness. The iCare DRSplus fundus imaging system is intuitive and requires minimal staff training. High-quality images are automatically and securely stored and forwarded for processing by AI. The report is instantly available and can be discussed with the patient during the same visit. AI instantly detects early signs of retinal pathology Artificial intelligence provides efficient processing for higher throughput and reliable results that match the level of a professional human grader.